Metraipolis › archive › dc_8fd7175cc01c

A Real-World Pharmacovigilance Analysis of the Safety Profiles Associated with Anti-MRSA Agents Using the Japanese Adverse Drug Event Report (JADER) Database — Europe PMC PMID:42201092

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42201092
DOI
10.3390/idr18030043
License (as archived)
solo-consultazione
Archived
2026-11-02T19:33:42.194Z
SHA-256 of the archived text
3e262f209e4cc2140f6278a44a614cb38cedf14a804d3aebb081900c809c7c96
Stable URL of this page
https://metraipolis.com/documento/dc_8fd7175cc01c

How to cite

A Real-World Pharmacovigilance Analysis of the Safety Profiles Associated with Anti-MRSA Agents Using the Japanese Adverse Drug Event Report (JADER) Database — Europe PMC PMID:42201092 — Europe PMC (en), https://europepmc.org/article/MED/42201092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8fd7175cc01c (Metraipolis archive dc_8fd7175cc01c, sha256 3e262f209e4cc2140f6278a44a614cb38cedf14a804d3aebb081900c809c7c96)
BibTeX
@misc{dc8fd7175cc01c,
  title = {A Real-World Pharmacovigilance Analysis of the Safety Profiles Associated with Anti-MRSA Agents Using the Japanese Adverse Drug Event Report (JADER) Database — Europe PMC PMID:42201092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42201092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8fd7175cc01c; sha256 3e262f209e4cc2140f6278a44a614cb38cedf14a804d3aebb081900c809c7c96},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42201092. Agents can read the archived copy with the MCP tool read_document.